These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26551520)

  • 1. Subacute cutaneous lupus erythematosus induced by capecitabine: 5-FU was innocent.
    Kim WI; Kim JM; Kim GW; Mun JH; Song M; Kim HS; Kim BS; Kim MB; Ko HC
    J Eur Acad Dermatol Venereol; 2016 Nov; 30(11):e163-e164. PubMed ID: 26551520
    [No Abstract]   [Full Text] [Related]  

  • 2. [Capecitabine-induced subacute cutaneous lupus: a case report].
    Fongue J; Meunier B; Lardet D; Dicostanzo MP; Rouby F; Terrier JP; Harlé JR; Richard MA; Chiche L
    Ann Dermatol Venereol; 2014 Oct; 141(10):593-7. PubMed ID: 25288062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The concurrence of subacute cutaneous lupus erythematosus and hand-foot syndrome in a patient undergoing capecitabine chemotherapy.
    Li Z; Jiang N; Xu Y
    Australas J Dermatol; 2016 Feb; 57(1):e14-6. PubMed ID: 25495707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of subacute cutaneous lupus erythematosus after treatment with fluorouracil and capecitabine.
    Weger W; Kränke B; Gerger A; Salmhofer W; Aberer E
    J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S4-6. PubMed ID: 18625380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic 5-fluorouracil induced lupus erythematosus: a review of the literature.
    Shakhbazova A; Marsch AF
    Dermatol Online J; 2019 Nov; 25(11):. PubMed ID: 32045142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capecitabine-induced Subacute Cutaneous Lupus Erythematosus.
    Rocha A; Almeida HL; Zerwes G; Oliveira Filho UL
    An Bras Dermatol; 2019; 94(5):618-619. PubMed ID: 31777367
    [No Abstract]   [Full Text] [Related]  

  • 7. Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy.
    Fernandes NF; Rosenbach M; Elenitsas R; Kist JM
    Arch Dermatol; 2009 Mar; 145(3):340-1. PubMed ID: 19289781
    [No Abstract]   [Full Text] [Related]  

  • 8. Occurrence of subacute cutaneous lupus erythematosus after treatment with systemic fluorouracil.
    Almagro BM; Steyls MC; Navarro NL; Domínguez EG; Acosta EH; Pérez MA; Ceballos EH
    J Clin Oncol; 2011 Jul; 29(20):e613-5. PubMed ID: 21537030
    [No Abstract]   [Full Text] [Related]  

  • 9. Subacute cutaneous lupus erythematosus induced by capecitabine.
    Floristan U; Feltes RA; Sendagorta E; Feito-Rodriguez M; Ramírez-Marín P; Vidaurrázaga C; Casado-Jiménez M
    Clin Exp Dermatol; 2009 Oct; 34(7):e328-9. PubMed ID: 19456774
    [No Abstract]   [Full Text] [Related]  

  • 10. Capecitabine-induced subacute cutaneous lupus erythematosus: report of a case with positive rechallenge test.
    Ko JH; Hsieh CI; Chou CY; Wang KH
    J Dermatol; 2013 Nov; 40(11):939-40. PubMed ID: 24111883
    [No Abstract]   [Full Text] [Related]  

  • 11. Subacute cutaneous lupus erythematosus after treatment with capecitabine.
    Kindem S; Llombart B; Requena C; Ruiz A; Traves V; Guillen C; San Martin O
    J Dermatol; 2013 Jan; 40(1):75-6. PubMed ID: 22937906
    [No Abstract]   [Full Text] [Related]  

  • 12. Capecitabine-induced coronary artery vasospasm in a patient who previously experienced a similar episode with fluorouracil therapy.
    Karakulak UN; Aladağ E; Maharjan N; Övünç K
    Turk Kardiyol Dern Ars; 2016 Jan; 44(1):71-4. PubMed ID: 26875134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subacute cutaneous lupus erythematosus induced by Capecitabine: Confocal microscopy and dermoscopy findings.
    Montero-Menárguez J; Gutiérrez-Collar C; Puerta-Peña M; Mitsunaga K; Peralto JLR; Velasco-Tamariz V
    Dermatol Ther; 2022 Sep; 35(9):e15705. PubMed ID: 35808972
    [No Abstract]   [Full Text] [Related]  

  • 14. Taxane associated subacute cutaneous lupus erythematosus.
    Marchetti MA; Noland MM; Dillon PM; Greer KE
    Dermatol Online J; 2013 Aug; 19(8):19259. PubMed ID: 24021438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docetaxel-induced-like subacute cutaneous lupus erythematosus.
    Verdelli A; Antiga E; Bonciani D; Bonciolini V; Volpi W; Maio E; Caproni M
    Clin Exp Dermatol; 2016 Apr; 41(3):318-9. PubMed ID: 26350359
    [No Abstract]   [Full Text] [Related]  

  • 16. Subacute Cutaneous Lupus Erythematosus Induced by Palbociclib.
    Pinard J; Patel M; Granter SR; Vleugels RA; Merola JF
    J Cutan Med Surg; 2018; 22(3):341-343. PubMed ID: 29307217
    [No Abstract]   [Full Text] [Related]  

  • 17. Subacute cutaneous lupus erythematosus induced by the new multikinase inhibitor pazopanib.
    Casado-Verrier B; Pérez-Santos S; Delgado-Mucientes C; Beato-Merino M
    Br J Dermatol; 2014 Dec; 171(6):1559-61. PubMed ID: 24909204
    [No Abstract]   [Full Text] [Related]  

  • 18. Docetaxel-induced relapse of subacute cutaneous lupus erythematosus and chilblain lupus.
    Lebeau S; També S; Sallam MA; Alhowaish A; Tschanz C; Masouyé I; Borradori L
    J Dtsch Dermatol Ges; 2013 Sep; 11(9):871-4. PubMed ID: 23848065
    [No Abstract]   [Full Text] [Related]  

  • 19. Subacute cutaneous lupus erythematosus induced by masitinib.
    Nieto-Rodríguez D; Gómez-Fernández C; Rueda-Carnero JM; Herranz-Pinto P
    Int J Dermatol; 2017 Nov; 56(11):1180-1181. PubMed ID: 28940367
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug Induced Lupus Erythematosus Due to Capecitabine and Bevacizumab Treatment Presenting with Prolonged Thrombocytopenia.
    Ozaslan E; Eroglu E; Gok K; Senel S; Baldane S; Akyol L; Ozkan M
    Rom J Intern Med; 2015; 53(3):282-5. PubMed ID: 26710505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.